Ubiquinol supplementation in elderly patients undergoing aortic valve replacement: biochemical and clinical aspects
Figure 5.NYHA class in placebo (grey) and QH treated (black) group in phase 1 and following 6-month follow-up. **p≤0.01 significance of differences in each experimental group in comparison with phase 1.